Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

NCT06307093

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +22 more
Locations
  • State Budgetary Healthcare Institution of the city of Moscow "Moscow City Oncological Hospital No. 62 of the Department of Health of the City of Moscow" Istra, Moscow Oblast, Russia
  • "New Clinic" LLC Pyatigorsk, Stavropol Territory, Russia
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary" Barnaul, The Altai Republic, Russia
  • Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic Cheboksary, The Chuvash Republic, Russia
View all 23 locations
View Trial Details
Completed

A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

NCT07435324

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • State Budgetary Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Oncological Dispensary" Arkhangelsk, Russia
  • State Budgetary Healthcare Institution "Regional Oncological Dispensary" Irkutsk, Russia
  • State Budgetary Healthcare Institution of Moscow "Moscow City Oncological Hospital No. 62, Department of Health of Moscow" Istra, Russia
  • Regional Budgetary Healthcare Institution "Ivanovo Regional Oncological Dispensary" Ivanovo, Russia
View all 34 locations
View Trial Details
Completed

A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

NCT07435311

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary" Barnaul, Russia
  • Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic Cheboksary, Russia
  • State Budgetary Healthcare Institution "Regional Oncological Dispensary" Irkutsk, Russia
  • State Budgetary Healthcare Institution of Moscow "Moscow City Oncological Hospital No. 62, Department of Health of Moscow" Istra, Russia
View all 18 locations
View Trial Details
Completed

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

NCT05249426

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • CTR Georges-François Leclerc Dijon, France
  • CTR Leon Berard Lyon, France
  • HOP Timone Marseille, France
View all 25 locations
View Trial Details
Completed

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

NCT04609566

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 90 locations
View Trial Details
Completed

Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer

NCT01772706

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +12 more
Locations
  • Institut de Cancerologie de l'Ouest Paul Papin Angers, France
  • Centre Guillaume le Conquérant Le Havre, France
  • Hôpital La Pitié Salpêtrière Paris, France
  • Centre hospitalier universitaire La Milétrie Poitiers, France
View Trial Details
Completed

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

NCT06366451

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • UC Davis Sacramento, California, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Oregon Health & Science University (OHSU) Portland, Oregon, United States
View Trial Details

Related conditions